Kadiri Sunil Kumar (40 results)

Condition: New.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book offers a detailed exploration of G-protein-coupled receptors (GPCRs), key membrane proteins that mediate cellular responses to diverse signals. It covers GPCR activation, regulation, structural advances, technological innovations, and drug discovery, emphasizing their crucial roles in physiology and therapy. By integrating molecular insights with clinical applications, the book bridges basic science and translational research in GPCR biology.GPCRs function as vital cellular communication hubs by activating guanine nucleotide-binding proteins (G proteins) to transduce extracellular signals into intricate intracellular pathways. These signaling cascades regulate processes such as cell growth, gene expression, and intercellular communication, crucial for maintaining cellular homeostasis. Disruptions in GPCR signaling are linked to diverse pathologies, making them prime targets for therapeutic intervention.The book begins with GPCR structure and activation mechanisms, followed by signaling networks and receptor regulation. It then covers breakthroughs in structural biology and cutting-edge research technologies. Drug discovery strategies, including allosterism and biased signaling, are explored next. Systems biology and molecular pathologies provide deeper insights into GPCR functions and diseases. The final chapters focus on cellular toxicity, preclinical to clinical drug development, and future research challenges.This resource is designed for researchers and scientists in molecular pharmacology, cell biology, and drug discovery, as well as graduate and postgraduate students. Pharmaceutical industry professionals, educators, trainees, and healthcare professionals engaged in GPCR-targeted therapies will also find this book an essential guide to the latest advances and clinical applications. …

Condition: New.

Condition: New. Prashant Tiwari, PhD, is an Associate Professor in the Department of Pharmacology at the College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, India. He has over a decade of experience in the field of teaching and research rel.

Condition: New. Prashant Tiwari, PhD, is an Associate Professor in the Department of Pharmacology at the College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, India. He has over a decade of experience in the field of teaching and research rel.

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Condition: New.

Hardback. Condition: New.

Buch. Condition: Neu. Neuware - As research continues to uncover the complex causes of Alzheimer's disease, a deeper understanding of its cellular and molecular mechanisms is essential for developing effective therapies. Cellular and Molecular Mechanisms in Alzheimer's Disease Therapeutics, a two volume set, provides a comprehensive examination of the processes driving disease onset and progression, bringing together leading experts to illuminate key pathways, therapeutic targets, and emerging treatment strategies. Volume 1: Cellular Mechanisms explores the cellular mechanisms underlying Alzheimer's disease-such as synaptic dysfunction, neuroinflammation, mitochondrial impairment, and protein aggregation-while highlighting their therapeutic implications, including personalized medicine, blood-brain barrier dynamics, and micro RNA-based approaches. Volume 2: Molecular Mechanisms examines AD at the molecular level-covering protein aggregation, cellular dysfunction, and neuroinflammation-while integrating emerging therapies, personalized approaches, and global research efforts to bridge fundamental mechanisms with clinical applications.…

Buch. Condition: Neu. Neuware - As research continues to uncover the complex causes of Alzheimer's disease, a deeper understanding of its cellular and molecular mechanisms is essential for developing effective therapies. Cellular and Molecular Mechanisms in Alzheimer's Disease Therapeutics, a two volume set, provides a comprehensive examination of the processes driving disease onset and progression, bringing together leading experts to illuminate key pathways, therapeutic targets, and emerging treatment strategies. Volume 1: Cellular Mechanisms explores the cellular mechanisms underlying Alzheimer's disease-such as synaptic dysfunction, neuroinflammation, mitochondrial impairment, and protein aggregation-while highlighting their therapeutic implications, including personalized medicine, blood-brain barrier dynamics, and micro RNA-based approaches. Volume 2: Molecular Mechanisms examines AD at the molecular level-covering protein aggregation, cellular dysfunction, and neuroinflammation-while integrating emerging therapies, personalized approaches, and global research efforts to bridge fundamental mechanisms with clinical applications.…

Condition: New.

Hardback. Condition: New.

Condition: New.

Hardcover. Condition: Brand New. 352 pages. 9.25x6.22x1.61 inches. In Stock.

Condition: New. 2026. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland.

Condition: New. 2026. 1st Edition. hardcover. . . . . .

PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Paperback. Condition: new. Paperback. Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features: -Overcomes the blood-brain barrier using advanced delivery methods.-Improves drug penetration & specificity with nano and polymer-based systems.-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.-Builds preclinical models & identifies biomarkers to support clinical success.-Designs regulatory-aligned clinical trial strategies for faster translation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Paperback. Condition: new. Paperback. Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features: -Overcomes the blood-brain barrier using advanced delivery methods.-Improves drug penetration & specificity with nano and polymer-based systems.-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.-Builds preclinical models & identifies biomarkers to support clinical success.-Designs regulatory-aligned clinical trial strategies for faster translation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt.

Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book offers a detailed exploration of G-protein-coupled receptors (GPCRs), key membrane proteins that mediate cellular responses to diverse signals. It covers GPCR activation, regulation, structural advances, technological innovations, and drug discovery, emphasizing their crucial roles in physiology and therapy. By integrating molecular insights with clinical applications, the book bridges basic science and translational research in GPCR biology.GPCRs function as vital cellular communication hubs by activating guanine nucleotide-binding proteins (G proteins) to transduce extracellular signals into intricate intracellular pathways. These signaling cascades regulate processes such as cell growth, gene expression, and intercellular communication, crucial for maintaining cellular homeostasis. Disruptions in GPCR signaling are linked to diverse pathologies, making them prime targets for therapeutic intervention.The book begins with GPCR structure and activation mechanisms, followed by signaling networks and receptor regulation. It then covers breakthroughs in structural biology and cutting-edge research technologies. Drug discovery strategies, including allosterism and biased signaling, are explored next. Systems biology and molecular pathologies provide deeper insights into GPCR functions and diseases. The final chapters focus on cellular toxicity, preclinical to clinical drug development, and future research challenges.This resource is designed for researchers and scientists in molecular pharmacology, cell biology, and drug discovery, as well as graduate and postgraduate students. Pharmaceutical industry professionals, educators, trainees, and healthcare professionals engaged in GPCR-targeted therapies will also find this book an essential guide to the latest advances and clinical applications. 402 pp. Englisch.…

Hardcover. Condition: new. Hardcover. As research continues to uncover the complex causes of Alzheimers disease, a deeper understanding of its cellular and molecular mechanisms is essential for developing effective therapies. Cellular and Molecular Mechanisms in Alzheimers Disease Therapeutics, a two volume set, provides a comprehensive examination of the processes driving disease onset and progression, bringing together leading experts to illuminate key pathways, therapeutic targets, and emerging treatment strategies. Volume 1: Cellular Mechanisms explores the cellular mechanisms underlying Alzheimers diseasesuch as synaptic dysfunction, neuroinflammation, mitochondrial impairment, and protein aggregationwhile highlighting their therapeutic implications, including personalized medicine, bloodbrain barrier dynamics, and micro RNA-based approaches. Volume 2: Molecular Mechanisms examines AD at the molecular levelcovering protein aggregation, cellular dysfunction, and neuroinflammationwhile integrating emerging therapies, personalized approaches, and global research efforts to bridge fundamental mechanisms with clinical applications. Explores the cellular processes in AD. Discusses how cellular mechanisms, such as synaptic dysfunction,neuroinflammation, mitochondrial impairment, and protein aggregation, contribute to the pathology of AD. Topics include blood-brain barrier dysfunction, personalized medicine based on genetic profiling, microRNAs in AD management of AD,etc. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Hardcover. Condition: new. Hardcover. As research continues to uncover the complex causes of Alzheimers disease, a deeper understanding of its cellular and molecular mechanisms is essential for developing effective therapies. Cellular and Molecular Mechanisms in Alzheimers Disease Therapeutics, a two volume set, provides a comprehensive examination of the processes driving disease onset and progression, bringing together leading experts to illuminate key pathways, therapeutic targets, and emerging treatment strategies. Volume 1: Cellular Mechanisms explores the cellular mechanisms underlying Alzheimers diseasesuch as synaptic dysfunction, neuroinflammation, mitochondrial impairment, and protein aggregationwhile highlighting their therapeutic implications, including personalized medicine, bloodbrain barrier dynamics, and micro RNA-based approaches. Volume 2: Molecular Mechanisms examines AD at the molecular levelcovering protein aggregation, cellular dysfunction, and neuroinflammationwhile integrating emerging therapies, personalized approaches, and global research efforts to bridge fundamental mechanisms with clinical applications. Discusses AD at a molecular level, from the misfolding and aggregation of amyloid-beta and tau proteins to disruptions in cellular homeostasis, mitochondrial dysfunction, and neuroinflammation. Presents new therapeutics for neurodegenerative disorders, behavioral intervention. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…